Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is injected subcutaneously — under the skin — at one of three licensed sites: the abdomen, the outer thigh, or the upper arm. Each site delivers the medicine into fatty tissue, and rotating between them week to week helps prevent soreness, lumps, or skin changes building up in any one spot. As a prescription-only medicine, Mounjaro is supplied following clinical assessment by a GPhC-registered prescriber; your Patient Information Leaflet and prescriber's advice are the definitive guide to your individual technique.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is designed for subcutaneous injection into one of three body areas: the abdomen, the outer thigh, or the outer upper arm. All three are equally effective when used correctly, what differs is convenience and how much fatty tissue is accessible at each location. The abdomen is the site most people start with, because you can see it clearly, you can pinch a fold easily, and both hands are free to manage the pen. Avoid the band of skin closest to your navel; anything within about 5 cm of it tends to be thinner and more sensitive. The outer thigh works well for self-injection and is a popular alternative when the abdomen needs a rest. Go for the fleshy outer section of the mid-thigh, not the inner thigh or the front where muscle sits close to the surface. The upper arm (the outer, fatty area) is the trickiest to self-inject because most people struggle to see or stabilise the skin without a mirror or a second pair of hands. If a family member or carer can help, it's a straightforward option that keeps the other two sites fresher. If you're unsure exactly where on your body to place the pen, our guide to where to do your Mounjaro shot walks through each area with practical detail. According to the NHS patient information for tirzepatide, all three sites are licensed and interchangeable week to week.
Spend a moment looking at the area you've chosen. The skin should be clean and unbroken, without any bruising, active redness, or raised, rubbery patches. Those raised patches (lipohypertrophy) form when the same square centimetre of skin absorbs repeated injections. They feel different from normal fat: firmer, sometimes almost painless because the nerve supply changes. Injecting into them isn't just uncomfortable; medicine absorbed through affected tissue enters the bloodstream unpredictably, which can blunt the effect of your dose. This one-minute check is genuinely useful: run your fingertips lightly over your usual spot before every injection. If anything feels different, move a few centimetres away. Alcohol swabs can be used to clean the site before injecting, let the skin dry completely before proceeding so the small sting from alcohol is gone. Your Patient Information Leaflet and full injection guidance explain the cleaning step in detail.
Rotation isn't just about using a different named site each week; it means moving within and between sites so no single patch of skin is reused within a short window. A practical approach: divide each site into small zones and work around them like a clock face before returning to where you started. Many people find a simple pattern helpful (abdomen this week, thigh next, upper arm the week after, then back to the abdomen but on the opposite side) so the rotation is automatic rather than something to remember in the moment. Detailed technique guidance covers how long to hold the pen against the skin and what to expect when the dose is delivered. If you notice persistent redness, swelling, or pain at any site that doesn't settle within a day or two, mention it to your prescriber. Cost context occasionally comes up at this stage too: understanding how UK Mounjaro pricing works can help you plan ongoing treatment alongside the practical side of using the pen. Once you've established a rotation that suits your lifestyle, the weekly injection tends to become a short, unremarkable routine.
As treatment progresses and body composition shifts, the best injection site can shift too. Some people find that a site that worked well at the start becomes less comfortable as subcutaneous fat redistributes. That's worth mentioning to your prescriber during a review, they can advise whether adjusting your primary site makes sense. Pregnancy, certain skin conditions, and surgical scarring can also affect which areas are suitable; your prescriber should know about any of these. If you're ever unsure about technique (a bent needle, a pen that seemed to click early, a dose that went somewhere it shouldn't) our team is available seven days a week for aftercare questions. The full Mounjaro injection overview covers storage, needle changes, and disposal alongside site selection. And if you're still in the stage of weighing up whether tirzepatide is the right option for your circumstances, the weight-loss treatment overview sets out how it sits alongside the other licensed options available in the UK.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.